Cannabis extracts from Switzerland

Cannabis is a narcotic. Cultivation, including for medicinal purposes, may only take place with a license from the Swiss Agency for Therapeutic Products Swissmedic in accordance with strict guidelines. Our cannabis cultivation is carried out by various close partners in Switzerland, all of whom have the necessary licenses. As far as possible, our products are grown organically in the open field and have the corresponding label.
Where this is not possible (due to specifications from the pharmaceutical sector), we still work as much as possible according to biological guidelines.

Cannapharm AG also has a license from the Federal Office of Public Health (FOPH) to breed and evaluate cannabis varieties. We have an increasing number of selected cannabis varieties that are kept in permanent vegetative growth as mother plants with the support of artificial light.

For the manufacture of products for medical use or scientific research, genetically identical clones are produced by propagation of cuttings, which are brought to flower in the field, in the greenhouse or under artificial light as required. All work, from propagation to growth, harvesting and processing of the plants, is carried out in accordance with GAP (Good Agricultural Practice) guidelines.

In a further step, the cannabis plants are processed into extracts, flowers or other galenic forms. Cannapharm AG has a license from Swissmedic for the manufacture and wholesale of medicinal products. All production and analytical work on our products is carried out with the utmost care in accordance with GMP (Good Manufacturing Practice).